ElucidVivo A.3 vs EchoGo Core
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
ElucidVivo A.3 and EchoGo Core are adjacent AI tools in cardiology, each addressing distinct diagnostic needs. ElucidVivo A.3 specializes in quantitative analysis of arterial plaque from CT angiography for atherosclerosis patient stratification. In contrast, EchoGo Core automates echocardiogram analysis to provide precise measurements of cardiac function, such as LV analysis.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
ElucidVivo A.3 is designed for integration with PACS/EMR systems, assisting physicians in atherosclerosis patient stratification and optimizing treatment decisions by providing detailed visualization and measurement of plaque characteristics. EchoGo Core offers vendor-neutral integration with existing PACS/EHR systems and can be set up quickly, often within 48 hours for cloud deployment, with reports accessible from anywhere.
ElucidVivo A.3 provides AI-powered quantitative analysis of arterial plaque, objectively quantifying Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, with plaque characteristics validated against histology. It also derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity, which has shown high accuracy compared to invasive FFR. EchoGo Core provides precise measurements for cardiac diagnosis through automated LV analysis (EF, GLS, LV volumes) and boasts zero inter- and intra-variability in its measurements, utilizing AI and machine learning algorithms for precise detection. Studies have shown EchoGo Core to be predictive of patient outcomes and more accurate than manual analysis for certain metrics.
ElucidVivo A.3 is designed for cardiology, radiology, and vascular surgery specialties, aiding in stratifying patients with atherosclerosis and optimizing treatment decisions through detailed plaque analysis from CT angiography. EchoGo Core is suited for cardiology, critical care, and emergency medicine, providing automated echocardiography analysis for confident cardiac diagnosis and improved patient outcomes, particularly for LV analysis in adult populations.
While not explicitly detailed for ElucidVivo A.3, its advanced quantitative analysis of arterial plaque aims to optimize treatment decisions and patient stratification. EchoGo Core is designed for rapid analysis and report generation (10-60 seconds processing time) and eliminates manual contouring, suggesting a quick integration into workflow with immediate efficiency gains and no special training required for operators.
The provided information does not detail specific support quality metrics or the availability of customer references for ElucidVivo A.3. For EchoGo Core, dedicated support and customer success teams are mentioned to offer guidance and insights to optimize workflow, and it is used in over 50 sites worldwide.
ElucidVivo A.3 is a software application that integrates with PACS/EMR systems, implying considerations for installation and integration across various IT infrastructures in a multi-site environment. EchoGo Core, as a cloud-based SaaS platform that also supports locally virtualized deployments, offers flexibility for multi-site rollouts through its cloud infrastructure and vendor-neutral integration with existing PACS/EHR systems, with rapid deployment possible.